A. Menarini Asia-Pacific Holdings Pte Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:A. Menarini Asia-Pacific Holdings Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013138
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions including R and D, biotech and diagnostics. Its R and D division access to global network of research and development infrastructure. A. Menarini Asia-Pacific’s biotech division develops and manufactures bio-pharmaceuticals, using mammalian cells and microbial production systems. The company’s diagnostics division provides technological solutions for healthcare professionals. It serves in the area of diabetes, autoimmunity, cell pathology, hemoglobin analysis, urine analysis, and others. A. Menarini Asia-Pacific is headquartered in Singapore.

A. Menarini Asia-Pacific Holdings Pte Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Invida Acquires Dermatology And Primary Care Product Portfolios From Shalaks Pharma For US$20 Million 10
Partnerships 12
Menarini Asia-Pacific Enters into Agreement with Merck 12
Moberg Pharma Extends Distribution Agreement With Menarini 13
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 14
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 15
Sinclair Pharma Extends Co-Marketing Agreement With Invida 16
Invida Group Enters Into Agreement With F. Hoffmann-La Roche 17
Licensing Agreements 19
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 19
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 20
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 21
Orexo Enters Into Licensing Agreement With Invida Group For Abstral 22
Acquisition 23
Menarini Group Acquires Invida 23
A. Menarini Asia-Pacific Holdings Pte Ltd – Key Competitors 25
A. Menarini Asia-Pacific Holdings Pte Ltd – Key Employees 26
A. Menarini Asia-Pacific Holdings Pte Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Other Significant Developments 29
Jun 09, 2016: Menarini Group and MSD Extends Global Partnership to the Asia-Pacific Region 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Key Facts 2
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
A. Menarini Asia-Pacific Holdings Pte Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
A. Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Invida Acquires Dermatology And Primary Care Product Portfolios From Shalaks Pharma For US$20 Million 10
Menarini Asia-Pacific Enters into Agreement with Merck 12
Moberg Pharma Extends Distribution Agreement With Menarini 13
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 14
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 15
Sinclair Pharma Extends Co-Marketing Agreement With Invida 16
Invida Group Enters Into Agreement With F. Hoffmann-La Roche 17
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 19
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 20
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 21
Orexo Enters Into Licensing Agreement With Invida Group For Abstral 22
Menarini Group Acquires Invida 23
A. Menarini Asia-Pacific Holdings Pte Ltd, Key Competitors 25
A. Menarini Asia-Pacific Holdings Pte Ltd, Key Employees 26
A. Menarini Asia-Pacific Holdings Pte Ltd, Subsidiaries 27

★海外企業調査レポート[A. Menarini Asia-Pacific Holdings Pte Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Pennsylvania:医療機器:M&Aディール及び事業提携情報
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Acadia Healthcare Company Inc:企業のM&A・事業提携・投資動向
    Acadia Healthcare Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acadia Healthcare Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Mentor Graphics Corporation:企業の戦略・SWOT・財務情報
    Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Meredith Corporation:企業の戦略・SWOT・財務分析
    Meredith Corporation - Strategy, SWOT and Corporate Finance Report Summary Meredith Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ra Pharmaceuticals Inc (RARX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • Ion Beam Applications SA (IBAB):企業の財務・戦略的SWOT分析
    Ion Beam Applications SA (IBAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Engepack Embalagens SA:企業の戦略・SWOT・財務情報
    Engepack Embalagens SA - Strategy, SWOT and Corporate Finance Report Summary Engepack Embalagens SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Physiomics Plc (PYC)-製薬・医療分野:企業M&A・提携分析
    Summary Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from pre-clinical research to clinical development and finding optim …
  • Mckinsey & Company, Inc.:企業の戦略・SWOT・財務分析
    Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sembcorp Industries Ltd (U96)-石油・ガス分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • Sumitomo Electric Industries Ltd (5802):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Electric Industries Ltd (Sumitomo) is a manufacturing company that develops, manufactures, and sells various products related to electronics, info communications, automotive, industrial materials, and environment and energy. The company’s product portfolio includes wiring harnesses, …
  • Talktalk Telecom Group PLC (TALK):企業の財務・戦略的SWOT分析
    Talktalk Telecom Group PLC (TALK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Rabigh Refining & Petrochemical Co (2380):企業の財務・戦略的SWOT分析
    Rabigh Refining & Petrochemical Co (2380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Fate Therapeutics Inc (FATE):製薬・医療:M&Aディール及び事業提携情報
    Summary Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidate …
  • Louisiana-Pacific Corporation:戦略・SWOT・企業財務分析
    Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Enterome Bioscience SA:医療機器:M&Aディール及び事業提携情報
    Summary Enterome Bioscience SA (Enterome) is a drug development company which develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome …
  • Changmao Biochemical Engineering Co., Ltd:戦略・SWOT・企業財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Didi Chuxing Co Ltd:企業の戦略的SWOT分析
    Didi Chuxing Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Transplant Genomics Inc:企業の製品パイプライン分析2018
    Summary Transplant Genomics Inc (TGI) is a biotech company. The company carries out performing organ transplantation using non-invasive serial monitoring under the guidance of genomics. It aims in detecting early signs of graft injury by conducting molecular diagnostic tests, enabling in differentia …
  • University of York-製薬・医療分野:企業M&A・提携分析
    Summary University of York (York) is an educational and research university that offers academic research and teaching services. The university offers commercial facilities and services, funding collaborative research, knowledge transfer partnerships, professional development and training, consultan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆